Cost-effectiveness of first-line immunotherapy for advanced non-small cell lung cancer with different PD-L1 expression levels: A comprehensive overview
- Resource Type
- Review Article
- Source
- In
Critical Reviews in Oncology / Hematology January 2024 193 - Subject
IMM - Language
- ISSN
- 1040-8428